Intramammary 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 treatments differentially increase serum calcium and milk cell gene expression
Intramammary 25-hydroxyvitamin D3 (25D) and 1,25-dihydroxyvitamin D3 (1,25D) treatments stimulate immune defenses of the mammary gland. We hypothesized 25D treatment, in contrast to 1,25D, would exert activity in the mammary gland without affecting serum calcium. The objective was to determine the e...
Main Authors: | T.L. Wells, M.B. Poindexter, M.F. Kweh, L.P. Blakely, C.D. Nelson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | JDS Communications |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666910222001478 |
Similar Items
-
Primary human osteoblasts in response to 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3.
by: Karen van der Meijden, et al.
Published: (2014-01-01) -
25-hydroxyvitamin D₃ and 1,25-dihydroxyvitamin D₃ promote the differentiation of human subcutaneous preadipocytes.
by: Hataikarn Nimitphong, et al.
Published: (2012-01-01) -
25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, and Peripheral Bone Densitometry in Adults with Celiac Disease
by: Carolina Ciacci, et al.
Published: (2020-03-01) -
Role of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 in Chicken Embryo Osteogenesis, Adipogenesis, Myogenesis, and Vitamin D3 Metabolism
by: Chongxiao Chen, et al.
Published: (2021-02-01) -
Treatment of an intramammary bacterial infection with 25-hydroxyvitamin D(3).
by: John D Lippolis, et al.
Published: (2011-01-01)